13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-09-18
4:35 pm
Purchase
2023-09-07 13G Mirum Pharmaceuticals, Inc.
MIRM
BIOTECHNOLOGY VALUE FUND L P 4,370,024
9.400%
4,370,024increase
(New Position)
Filing
History
2023-09-14
4:23 pm
Purchase
2023-09-12 13D Olema Pharmaceuticals, Inc.
OLMA
BIOTECHNOLOGY VALUE FUND L P 9,135,893
16.700%
1,724,390increase
(+23.27%)
Filing
History
2023-08-17
4:52 pm
Unchanged
2023-08-10 13D Rain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P 3,526,729
12.800%
0
(Unchanged)
Filing
History
2023-08-17
4:49 pm
Unchanged
2023-08-10 13D Pieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P 257,623
20.800%
0
(Unchanged)
Filing
History
2023-08-10
4:34 pm
Purchase
2023-07-31 13G Forte Biosciences, Inc.
FBRX
BIOTECHNOLOGY VALUE FUND L P 119,284
8.200%
119,284increase
(New Position)
Filing
History
2023-07-06
5:23 pm
Purchase
2023-06-26 13G Unicycive Therapeutics, Inc.
UNCY
BIOTECHNOLOGY VALUE FUND L P 3,470,225
9.990%
3,470,225increase
(New Position)
Filing
History
2023-06-30
4:41 pm
Unchanged
2023-06-27 13D MoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P 21,751,284
35.800%
0
(Unchanged)
Filing
History
2023-06-30
4:33 pm
Purchase
2023-06-22 13G Revolution Medicines, Inc.
RVMD
BIOTECHNOLOGY VALUE FUND L P 7,555,588
7.100%
5,745,039increase
(+317.31%)
Filing
History
2023-06-28
1:51 pm
Sale
2023-06-26 13D CTI BioPharma Corp.
CTIC
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-28,463,021decrease
(Position Closed)
Filing
History
2023-06-22
4:47 pm
Purchase
2023-06-12 13G Delcath Systems, Inc.
DCTH
BIOTECHNOLOGY VALUE FUND L P 1,561,514
9.990%
1,561,514increase
(New Position)
Filing
History
2023-06-05
4:45 pm
Purchase
2023-05-26 13G TScan Therapeutics, Inc.
TCRX
BIOTECHNOLOGY VALUE FUND L P 4,414,910
9.990%
4,414,910increase
(New Position)
Filing
History
2023-05-30
4:45 pm
Purchase
2023-05-17 13G Janux Therapeutics, Inc.
JANX
BIOTECHNOLOGY VALUE FUND L P 4,106,945
9.800%
4,106,945increase
(New Position)
Filing
History
2023-05-22
4:47 pm
Purchase
2023-05-11 13D Pieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P 257,623
22.000%
161,448increase
(+167.87%)
Filing
History
2023-03-24
4:33 pm
Purchase
2023-03-14 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 2,455,089
5.100%
250,000increase
(+11.34%)
Filing
History
2023-03-20
5:04 pm
Purchase
2023-03-10 13G Protagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P 5,025,900
9.600%
3,775,900increase
(+302.07%)
Filing
History
2023-03-16
4:48 pm
Purchase
2023-03-06 13G Aclaris Therapeutics, Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P 3,360,941
5.000%
84,398increase
(+2.58%)
Filing
History
2023-03-06
5:10 pm
Purchase
2023-02-24 13G ASLAN Pharmaceuticals Limited
ASLN
BIOTECHNOLOGY VALUE FUND L P 1,061,000
9.990%
1,061,000increase
(New Position)
Filing
History
2023-02-14
12:10 pm
Sale
2022-12-31 13G Molecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P 4,510,072
12.600%
-16,210decrease
(-0.36%)
Filing
History
2023-02-14
12:05 pm
Purchase
2022-12-31 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 2,205,089
4.600%
240,230increase
(+12.23%)
Filing
History
2023-02-14
12:03 pm
Sale
2022-12-31 13G Galmed Pharmaceuticals Ltd.
GLMD
BIOTECHNOLOGY VALUE FUND L P 9,665
6.900%
-333decrease
(-3.34%)
Filing
History
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...17, 18, Next